Literature DB >> 28275412

Clostridium Difficile Colitis in Trauma Patients - a Global Step by Step Review.

Silviu Morteanu1, Georgiana Chirt2, Mircea Beuran1.   

Abstract

Clostridium difficile associated disease is a well recognized nosocomial infection evolving as a severediarrheal illness, associated with significantly higher rates of morbidity and mortality in critically ill patients. The incidence of Clostridium difficile infection is higher and its impact is more severe in trauma patients when compared with general inpatient population. There are several potential diagnosis tools for Clostridium difficile colitis, however choosing the right diagnostic approach is a difficult task, especially in trauma patients in whom a rapid and certain diagnosis is of paramount importance. Moreover, managing these patients may prove to be a very challenging task, considering the emergence of novel aggressive Clostridium difficile strains resulting in increased disease severity.

Entities:  

Year:  2015        PMID: 28275412      PMCID: PMC5327811     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  29 in total

1.  Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients.

Authors:  Laurent G Glance; Pat W Stone; Dana B Mukamel; Andrew W Dick
Journal:  Arch Surg       Date:  2011-03-21

Review 2.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

3.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

4.  Clostridium difficile-associated disease acquired in the neurocritical care unit.

Authors:  S A Musa; H Robertshaw; S J Thomson; M L Cowan; T M Rahman
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

5.  Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.

Authors:  Alicia Olson; Lawrence N Diebel; David M Liberati
Journal:  J Trauma Acute Care Surg       Date:  2014-10       Impact factor: 3.313

6.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Authors:  Johannes Aas; Charles E Gessert; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2003-02-14       Impact factor: 9.079

7.  Clostridium difficile-associated disease acquired in the cardiothoracic intensive care unit.

Authors:  Saif A Musa; Carl Moran; Sam J Thomson; Matthew L Cowan; Greg McAnulty; Michael Grounds; Tony Manibur Rahman
Journal:  J Cardiothorac Vasc Anesth       Date:  2011-04       Impact factor: 2.628

8.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 9.  New trends in Clostridium difficile virulence and pathogenesis.

Authors:  C Denève; C Janoir; I Poilane; C Fantinato; A Collignon
Journal:  Int J Antimicrob Agents       Date:  2009-03       Impact factor: 5.283

10.  Mortality and Clostridium difficile infection: a review.

Authors:  Brett G Mitchell; Anne Gardner
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.